GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Minority Interest

Bausch Health (TSX:BHC) Minority Interest : C$1,262.49 Mil (As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Bausch Health's minority interest for the quarter that ended in Sep. 2024 was C$1,262.49 Mil.

Bausch Health Minority Interest Historical Data

The historical data trend for Bausch Health's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Minority Interest Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.13 89.66 92.16 1,293.29 1,261.10

Bausch Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,278.68 1,261.10 1,273.74 1,299.23 1,262.49

Bausch Health Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Bausch Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Minority Interest
Comparable Companies
XCNQ:GTII TSX:CURA XCNQ:TRUL TSX:CRON NEOE:GLAS.A.U NEOE:VRNO TSX:DHT.U TSX:WEED TSX:GUD XCNQ:CL ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
BHC:USA BHC:Mexico BVF:Germany BVF:Germany
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Website
https://www.bauschhealth.com
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Lynne Carson Senior Officer
Robert Allen Spurr Senior Officer
Joseph Gordon Senior Officer
Steven Daniel Miller Director
Andrew Charles Von Eschenbach Director
Richard Urbain De Schutter Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler Director
William Douglas Humphries Senior Officer
John Paulson Director
Thomas Ross Sr. Director
Christina Ackermann Senior Officer
Joseph Papa Director, Senior Officer
Paul Herendeen Senior Officer